Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 04.05.2026 1 Acta Neuropathol 2 Childs Nerv Syst 5 Clin Cancer Res 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 6 J Neurooncol 1 J Neuropathol Exp Neurol 2 J Neurosurg 5 Neuro Oncol 1 Neuroradiology 1 Neurosurgery 1 PLoS Genet 1 PLoS One 2 Radiol Artif Intell

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. RAHMANZADE R, Schweizer L, Schmid S, Lausova T, et al
   Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.
   Acta Neuropathol. 2026;151:46.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

2. SHAH KH, Guerrero-Ocampo MJ, Flecha IG, Roach CS, et al
   Impact of chemotherapy and immunotherapy on survival in pediatric primary diffuse leptomeningeal melanomatosis: a systematic review and pooled survival analysis.
   Childs Nerv Syst. 2026;42:189.
   PubMed         Abstract available
   
   
3. CHIMATIRA R
   Rosette-forming glioneuronal tumor of the cerebellum with intratumoral hemorrhage: case report with radiologic-pathologic correlation in a resource-limited setting.
   Childs Nerv Syst. 2026;42:186.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

4. XU Q, Huang K, Meng X, Weng Y, et al
   Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
   Clin Cancer Res. 2026;32:1913.
   PubMed        
   
   
5. TIU C, Yau W, Silva D, Waldron N, et al
   Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma.
   Clin Cancer Res. 2026 Apr 27. doi: 10.1158/1078-0432.CCR-25-4364.
   PubMed         Abstract available
   
   
6. WILLIAMS MM, Haskell-Mendoza AP, Massat EA, Mott BT, et al
   Contemporary Management of Radiation Necrosis: Insights and Avenues.
   Clin Cancer Res. 2026;32:1606-1614.
   PubMed         Abstract available
   
   
7. GRIGUOLO G, Bottosso M, Landa G, Bonomi G, et al
   Proactive brain screening using contrast-enhanced brain CT scans in HER2+ metastatic breast cancer.
   Clin Cancer Res. 2026 Feb 9. doi: 10.1158/1078-0432.CCR-25-3557.
   PubMed         Abstract available
   
   
8. LEE EJ, Ko JA, Kim MJ, Cho JS, et al
   JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.
   Clin Cancer Res. 2026;32:1835-1845.
   PubMed         Abstract available
   
   

   
   Int J Cancer

9. SALIM SK, Shaikh MV, Wei J, Maich WT, et al
   Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.
   Int J Cancer. 2026 Apr 24. doi: 10.1002/ijc.70509.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

10. WISDOM AJ, Temple H, Cui Y, Vecchio CTD, et al
    Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma.
    Int J Radiat Oncol Biol Phys. 2026 Apr 22:S0360-3016(26)00587.
    PubMed         Abstract available
    
    

    
    J Neurooncol

11. GAGLIARDI F, De Domenico P, Roncelli F, Snider S, et al
    Circulating Angiopoietin-1/Angiopoietin-2 ratio may reflect pre- and post-treatment vascular states in Glioblastoma and improve discrimination between tumor recurrence and radiation necrosis.
    J Neurooncol. 2026;177:123.
    PubMed        
    
    
12. MAURICAITE R, Calvez KL, Robinson SD, Camp S, et al
    Variation in rates of post-operative oncological treatment for patients with glioblastoma in England: a comprehensive multi-year National cohort study from the GlioCova project.
    J Neurooncol. 2026;177:126.
    PubMed         Abstract available
    
    
13. FRIEDES C, Berger M, Linkowski L, Hollawell C, et al
    Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
    J Neurooncol. 2026;177:125.
    PubMed         Abstract available
    
    
14. MA Y, Zhou R, Ma Y, Mou C, et al
    Application of multidimensional cognitive training in the early postoperative period for glioma patients with cognitive impairment.
    J Neurooncol. 2026;177:128.
    PubMed        
    
    
15. GOULENKO V, Sinha S, Gulzar B, Madhugiri VS, et al
    Longitudinal remodeling of brain metastasis resection cavities after adjuvant gamma knife radiosurgery.
    J Neurooncol. 2026;177:129.
    PubMed         Abstract available
    
    
16. GOODIN DA, Chen J, Williams BJ, Frieboes HB, et al
    Glioblastoma region-specific metabolic signatures reflect patient survival duration.
    J Neurooncol. 2026;177:130.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

17. HIGA N, Akahane T, Yokoyama S, Yonezawa H, et al
    Molecular and clinical prognostic factors in isocitrate dehydrogenase-mutant astrocytomas: Insights into biomarker-driven stratification.
    J Neuropathol Exp Neurol. 2026;85:455-463.
    PubMed         Abstract available
    
    

    
    J Neurosurg

18. LUO C, Song Y, Zhu G, Zhang X, et al
    The efficacy and safety of sublobectomy for glioblastoma: a propensity score-weighted study.
    J Neurosurg. 2026 Apr 24:1-14. doi: 10.3171/2025.12.JNS251341.
    PubMed         Abstract available
    
    
19. LEE KE, Catapano JS, Eschbacher JM, Rogers CL, et al
    Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants for recurrent aggressive meningiomas: 5-year results from a prospective phase 2 trial.
    J Neurosurg. 2026 Apr 24:1-8. doi: 10.3171/2025.12.JNS25868.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

20. FEDERICO A, Schmitt-Hoffner F, Fonseca A, Geisemeyer N, et al
    Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies.
    Neuro Oncol. 2026;28:1005-1019.
    PubMed         Abstract available
    
    
21. DARLIX A, Bady P, Deverdun J, Bars EL, et al
    Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.
    Neuro Oncol. 2026;28:911-922.
    PubMed         Abstract available
    
    
22. RAJAN S, Chung HJ, Wu Z, Singh O, et al
    Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases.
    Neuro Oncol. 2026;28:939-951.
    PubMed         Abstract available
    
    
23. YANG C, Cai H, Liu W, Wang J, et al
    Cerebrospinal fluid metabolomics and machine learning identify novel biomarkers for lung cancer leptomeningeal metastasis.
    Neuro Oncol. 2026;28:980-993.
    PubMed         Abstract available
    
    
24. OZDEMIR Z, Gallus M, Muther M, Stummer W, et al
    5-ALA-mediated PpIX Accumulation in the Tumor Microenvironment of Glioma and its Implications for 5-ALA-based Local Tumor Therapies: A Review of the Literature.
    Neuro Oncol. 2026 Apr 30:noag094. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

25. REYES JS, Almeida T, Bouras A, Mettenburg J, et al
    Radiomics-based artificial intelligence models in brain tumors: A systematic review and meta-analysis of diagnostic performance.
    Neuroradiology. 2026 Apr 27. doi: 10.1007/s00234-026-03983.
    PubMed        
    
    

    
    Neurosurgery

26. YURTLUK MD, Wei CZ, Reyes JS, Puccio D, et al
    Primary Versus Adjuvant Stereotactic Radiosurgery for Cavernous Sinus Meningiomas: A Propensity Score-Matched Comparative Analysis.
    Neurosurgery. 2026 Apr 30. doi: 10.1227/neu.0000000000004071.
    PubMed         Abstract available
    
    

    
    PLoS Genet

27. ZHOU L, Che H, Jiang H, Yin L, et al
    Nebivolol suppresses glioblastoma progression via dual modulation of mitochondrial metabolism and AKT/mTOR/4EBP1 signaling axis.
    PLoS Genet. 2026;22:e1012120.
    PubMed         Abstract available
    
    

    
    PLoS One

28. AL-ROBAIY S, Hohmann U, Simm A, Dehghani F, et al
    An optimized protocol for metabolic measurement in 3D tumor spheroids derived from primary and established glioblastoma cells.
    PLoS One. 2026;21:e0347569.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

29. FATHI KAZEROONI A, Jiang Z, Gandhi D, Khalili N, et al
    Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.
    Radiol Artif Intell. 2026 Apr 29:e250902. doi: 10.1148/ryai.250902.
    PubMed         Abstract available
    
    
30. LEE J, Jeon YH, Jang J, Eum H, et al
    Deep Learning for Survival Prediction in Glioblastoma: Time-dependent Model Interpretability Using MRI, Clinical, and Molecular Data.
    Radiol Artif Intell. 2026 Apr 29:e250675. doi: 10.1148/ryai.250675.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum